Top Markets
#1 Black Phoenix Black Phoenix +743.63%
#2 Islamic Coin Islamic Coin +146.07%
#3 Beam Beam +32.83%
#4 THORChain THORChain +25.51%
#5 TENDIES TENDIES +19.49%
#6 THORChain Yield THORChain Yield +19.43%
#7 SAFEcoin SAFEcoin +18.45%
#8 MiL.k Alliance MiL.k Alliance +16.38%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +16.02%
#10 Bless Bless +15.60%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Classifica tra le azioni #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Prezzo delle azioni
$93.80
Ultima sincronizzazione: 2025-04-28
Capitalizzazione di mercato
$2.68B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Aerovate Therapeutics, Inc. (AVTE)

Categoria

Healthcare
Rapporto P/B per Aerovate Therapeutics, Inc. (AVTE)
Rapporto P/B al August 2026 TTM: 0.37
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Aerovate Therapeutics, Inc., il rapporto P/B attuale (TTM) è 0.37. Alla fine del 2023, era pari a 5.44.
Storico del rapporto P/B per Aerovate Therapeutics, Inc. da 2020 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 0.37 -100.02%
2024 -1.62K -29,830.16%
2023 5.44 -3.77%
2022 5.66 238.93%
2021 1.67 -99.12%
2020 189.49 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 1,605.27%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 1,578.22%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 897.23%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 573.68%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH